XAIR
Beyond Air, Inc.
1W: -11.5%
1M: -25.5%
3M: -19.5%
YTD: -12.5%
1Y: -88.2%
3Y: -99.5%
5Y: -99.4%
$0.69
-0.05 (-6.74%)
After Hours: $0.74 (+0.05, +7.25%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$3.5M
52W Range0.673-6.4
Volume204,885
Avg Volume7,792,518
Beta0.42
Dividend—
Analyst Ratings
Company Info
CEOSteven Adam Lisi
Employees107
SectorHealthcare
IndustryMedical - Devices
IPO Date2018-06-12
Websitebeyondair.net
900 Stewart Avenue
Garden City, NY 11530
US
Garden City, NY 11530
US
516 665 8200
About Beyond Air, Inc.
Beyond Air, Inc. operates as a commercial medical device and biopharmaceutical company. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired viral pneumonia, including COVID-19, as well as bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is based in Garden City, New York.
Latest News
Beyond Air CEO Steve Lisi resigns, Robert Goodman appointed successor
Beyond Air, Inc. Announces Resignation of Steve Lisi, CEO, and Appointment of Robert Goodman, Chief Commercial Officer, as CEO
Beyond Cancer Reports Early Clinical Activity and Favorable Safety Profile with Interim Data from Phase 1 UNO Trial
Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing
Beyond Air to Participate in the 38th Annual Roth Conference in March
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| MOORHEAD DANIEL J | A-Award | 70,000 | $0.79 | 2026-01-05 |
| MOORHEAD DANIEL J | 0 | — | 2026-01-05 | |
| Lee Yoori | A-Award | 3,750 | $1.95 | 2025-11-04 |
| Lee Yoori | A-Award | 2,250 | $1.95 | 2025-11-04 |
| Lee Yoori | A-Award | 2,000 | $1.95 | 2025-11-04 |